PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Disease Reportsepidermolysis bullosa
MeSH D004820 - epidermolysis bullosa
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D012873:Genetic skin diseases
$
Success rate
D012868:Skin abnormalities
0 Companies
0 Drugs
Success rate
D012872:Vesiculobullous skin diseases
0 Companies
0 Drugs
Success rate
D004820: 
Epidermolysis bullosa
$
Success rate
D016108:Epidermolysis bullosa dystrophica
0 Drugs
Success rate
D016109:Junctional epidermolysis bullosa
0 Drugs
Success rate
D016110:Epidermolysis bullosa simplex
0 Companies
0 Drugs
Success rate
D016107:Epidermolysis bullosa acquisita
0 Companies
0 Drugs
Success rate
Events Timeline
Loading
Commercial
No Data
Clinical Trials
Historical Success Rate
Phase 1
73%
11/15
Phase 2
8%
1/13
Phase 3
0%
0/6
Approved: 0Overall Success rate: 0%
All Clinical Trials
No data
© 2020-2023 Collaborative Drug Discovery Inc. (CDD) | Terms of Use